Overall rank by patents
#813
Across all tracked assignees
USPTO PatentsView assignee record - 565 granted patents across 154 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B32B (LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM).
The verdict
Sekisui holds 565 US patents across 154 technology areas, rank #813 of 50,000 tracked assignees.
Sekisui Chemical Co., Ltd. has been granted 565 US utility patents between 2015 and 2025, placing Sekisui Chemical Co., Ltd. at rank #813 across all assignees tracked by PlainPatent. This portfolio spans 154 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.0 claims per patent with primary concentration in B32B (LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM). As a Foreign Corporation, Sekisui Chemical Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Sekisui sits between The Cleveland Clinic Foundation (570 patents, rank #809) and Gilead Sciences, Inc. (561 patents, rank #817) - the closest US assignees by grant volume. The composite Innovation Score of 60.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 372 grants, compared with 193 in the 2015–2019 window, a +93% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Sekisui Chemical Co., Ltd.'s 11.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sekisui Chemical Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
The Cleveland Clinic Foundation
570 patents
Wonderland Switzerland AG
570 patents
Hill-Rom Services, Inc.
569 patents
Tetra Laval Holdings & Finance S.A.
568 patents
SEKISUI CHEMICAL CO., LTD.
565 patents
Polaris Industries Inc.
563 patents
Under Armour, Inc.
563 patents
Electronic Arts Inc.
561 patents
Gilead Sciences, Inc.
561 patents
What this shows Sekisui holds 565 patents at rank #813, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #813 in granted patent volume.
Other assignees with the most granted patents in Sekisui's primary technology class.
Sekisui's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
60 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 27 | 4.8% |
| 2016 | 34 | 6.0% |
| 2017 | 35 | 6.2% |
| 2018 | 38 | 6.7% |
| 2019 | 59 | 10.4% |
| 2020 | 69 | 12.2% |
| 2021 | 63 | 11.2% |
| 2022 | 77 | 13.6% |
| 2023 | 56 | 9.9% |
| 2024 | 60 | 10.6% |
| 2025 | 47 | 8.3% |
Top 15 of 154 technology areas
Overall rank by patents
#813
Across all tracked assignees
60.2 out of 100
How to use this portfolio
Sekisui's 565 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.